Home
About us
News
Products
Innovation
CMO/CDMO Services
Contact
中文
undefined
Jiudian Pharmaceutical Introduces Breakthrough Pain Relief Drug to Accelerate Innovation in Pain Management
On December 15, 2025, Mr. Lan, the Party Secretary of Nanjing Medical University, and Mr. Li, Chairman of Suzhou Yuanju Pharmaceutical, along with a delegation of over ten individuals, visited Jiudian Pharmaceutical to witness the official signing of the innovation drug project transfer agreement between Jiudian Pharmaceutical and Yuanju Pharmaceutical. According to the agreement, Jiudian Pharmaceutical will acquire global ownership and intellectual property rights of the small molecule pain relief innovation drug YJ2301 for a total amount not exceeding 400 million yuan.
18
2025
/
12
Jiudian Pharmaceutical Successfully Holds the Fourth Session of the Fourth Employee Representative Congress
On December 10th, Jiudian Pharmaceutical successfully held the fourth session of the fourth Employee Representative Congress. The meeting was hosted by Ms. Liu, Chair of the Jiudian Pharmaceutical Trade Union, and took place in two locations, the Jiudian Headquarters and the Jiudian Production Center. The event was conducted in a hybrid format, combining both online and offline participation. A total of 95 employee representatives attended, fulfilling their democratic management responsibilities. During the session, the Employee Representative Directors of the fourth board of directors were elected, and 15 human resource management regulations were reviewed and passed unanimously. These measures aim to standardize labor management, safeguard employee rights, and lay a solid foundation for energizing the team.
“Change Your Pain Patch, Change to Jiudian” - Jiudian Pharmaceutical Launches Brand Revitalization
On December 6, 2025, Jiudian Pharmaceutical held the “Change Your Pain Patch, Change to Jiudian” brand upgrade press conference, inviting over 300 key executives from mainstream pharmacy chains and commercial companies across China to witness the company’s comprehensive revitalization in the external pain relief field. The company officially began its strategic transformation from a “product-centric” focus to a “dual-core” drive of both “products and brand,” with a clearer image and positioning to expand the vast potential of the outpatient market.
08
Love and Support for the Future: The 2025 "Jiudian Pharmaceutical Scholarship" Award Ceremony at Hunan Normal University
On the morning of December 3rd, the 2025 "Jiudian Pharmaceutical Scholarship" award ceremony for the College of Chemistry and Chemical Engineering at Hunan Normal University (HNU) was held in the Chemistry Building. The ceremony was attended by Ms. Yang, Human Resources Director of Jiudian Pharmaceutical, Mr. Tan, Party Secretary of the College, Mr. Zhou, Deputy Party Secretary, Ms. Song, Associate Dean, along with other faculty members, and all the scholarship recipients.
05
A New Addition to High-End Pharmaceutical Excipients: Jiudian HongYang's Injectable Xylitol Approved for Market
Recently, the pharmaceutical excipient Xylitol (for injection) (F20220000142) from Jiudian Hongyang has been approved by the National Medical Products Administration (NMPA) and has successfully transitioned from the "I" (initial registration) to the "A" (approved) status in the China Drug Evaluation Center (CDE). This marks a significant milestone for the company as the product passes review and is now approved for market release.
Jiudian Pharmaceutical Honored as "2025 A-Share Listed Company Growth Enterprise of the Year"
On December 2nd, at the “Future 20·2025 Annual Selection of Small and Mid-Cap Growth Enterprises among A-Share Listed Companies” held in Shanghai, Jiudian Pharmaceutical was awarded the title of "2025 A-Share Listed Company Growth Enterprise of the Year" jointly presented by China Business Network (CBN), Ernst & Young (China) and SIA Asset Management. The award recognized the company’s outstanding innovation capability, steady operating performance and remarkable growth potential. Ms. Zeng, Deputy General Manager and Board Secretary of Jiudian Pharmaceutical, attended the event and accepted the award on behalf of the company.
Endless Vitality, "Ping"ing Excellence: The Jiudian HongYang Table Tennis Tournament Concludes Successfully
Recently, the employee table tennis tournament organized by the Jiudian HongYang Trade Union successfully concluded. The event aimed to relieve employees' work pressure, foster a positive and healthy corporate culture, promote cross-departmental communication and collaboration, and further strengthen team cohesion and sense of belonging. The competition attracted 22 participants from various departments, and after more than 16 intense matches, the top three winners in both men's and women's singles were determined.
03
Laughter Builds Trust, Collaboration Fosters Growth
On November 28, Workshop 601 of Jiudian Hongyang organized a team-building activity themed “Join Forces to Move Forward, Work Together to Create the Future” at the Community Center.Employees strengthened communication and honed team spirit through fun games, skill challenges, and collaborative exercises in a relaxed and enjoyable atmosphere.
02